TL;DR
This study reveals that Porcine Hemagglutinating Encephalomyelitis Virus (PHEV) infection triggers the host's Unfolded Protein Response (UPR) pathway, specifically the PERK and PKR branches. This activation leads to a shutdown of global protein synthesis and the formation of stress granules, ultimately inhibiting viral replication. These findings highlight a crucial host defense mechanism against coronaviruses and identify potential therapeutic targets for antiviral drug development.
What Problem Does This Paper Address?
Coronaviruses, including the infamous SARS-CoV-2, are known to hijack the host cell's endoplasmic reticulum (ER) for replication. This often leads to ER stress (ERS) and the activation of the Unfolded Protein Response (UPR), a cellular defense mechanism. However, the precise role of virus-induced ERS in regulating coronavirus replication, particularly for neurotropic betacoronaviruses like PHEV, remains poorly understood. PHEV causes severe neurological damage and high mortality in piglets, making it an important animal pathogen. This paper aims to elucidate how PHEV infection impacts the ER and UPR, and how these cellular responses, in turn, affect viral replication, especially in nerve cells.
Methods
The researchers employed a multi-pronged approach to investigate the interplay between PHEV infection and the host's UPR:
- Transmission Electron Microscopy (TEM): To visualize structural changes in the ER of infected cells and mouse brains.
- Western Blotting: To detect the expression levels of key ER stress markers (GRP78/Bip, GRP94, calnexin, PDI) and UPR signaling proteins (PERK, p-PERK, eIF2α, p-eIF2α, PKR, p-PKR, GCN2, p-GCN2, ATF6, ATF6-Nt, PHEV-N).
- RT-qPCR: To quantify mRNA levels of UPR-related genes (Xbp1s, Xbp1u, ERdj4, p58(IPK), Atf4, Chop, Gadd34, Grp78, Grp94, Calreticulin) and viral RNA.
- siRNA Knockdown and Plasmid Transfection: To specifically inhibit or overexpress components of the UPR pathway (IRE1, ATF6, eIF2α, G3BP1, TIA1) and assess their impact on viral replication.
- Pharmacological Inhibition/Activation: Using chemical inducers (tunicamycin, thapsigargin) and inhibitors/activators (4-PBA, 4µ8C, AA147, Ceapin-A7, GSK2606414, salubrinal, C16) to manipulate specific UPR pathways.
- SUNSET Assay: A non-radioactive method to monitor nascent protein synthesis and assess global protein translation.
- Immunofluorescence Microscopy: To visualize the localization of viral proteins and stress granule markers (G3BP1).
- Cell Viability Assays (CCK-8): To ensure that observed effects were not due to general cytotoxicity of the treatments.
- Viral Titer Assays (TCID50): To quantify infectious viral particles.
Datasets
Not discussed in the paper. The study primarily relies on experimental data generated from cell cultures and animal models.
Key Insights and Ideas
- PHEV is a potent ER stress inducer: The virus doesn't just replicate; it actively disrupts the ER structure and triggers a significant cellular stress response.
- The UPR is a double-edged sword: While all three branches of the UPR are activated, the PERK/PKR-eIF2α axis acts as a crucial antiviral defense, whereas the ATF6 pathway appears to be pro-viral. This highlights the complex and context-dependent nature of cellular responses to infection.
- Global protein translation shutdown is key: The PERK/PKR-eIF2α pathway's primary antiviral mechanism is to broadly halt protein synthesis, starving the virus of essential building blocks.
- Stress granules as antiviral factories: Phosphorylated eIF2α promotes the formation of stress granules, which are then shown to actively inhibit viral replication. This suggests SGs are not just passive bystanders but active players in the antiviral arsenal.
- Potential for novel antiviral targets: The identification of PERK, PKR, and eIF2α as key regulators of PHEV replication opens doors for developing new therapeutic strategies against PHEV and potentially other coronaviruses.
Key Results
- PHEV infection induced ER stress and activated all three branches of the UPR (IRE1, PERK, and ATF6) in both in vitro (N2a cells) and in vivo (mouse brains).
- ERS significantly suppressed PHEV replication, primarily through the PERK-eIF2α pathway.
- PKR, another eIF2α kinase, was also activated by PHEV infection and worked cooperatively with PERK to inhibit viral replication.
- The PERK/PKR-eIF2α pathway inhibited PHEV replication by attenuating global protein translation, as evidenced by reduced nascent protein synthesis.
- Phosphorylated eIF2α promoted the formation of stress granules (SGs), which were found to repress PHEV replication.
- Inhibition of the IRE1 pathway had no significant effect on PHEV replication.
- Activation of the ATF6 pathway (using AA147) promoted PHEV replication, while inhibition (using Ceapin-A7) reduced it, suggesting a pro-viral role for ATF6.
- Knockdown of eIF2α significantly increased PHEV replication, confirming its essential role in the antiviral response.
Limitations and Future Work
- ATF6 mechanism: While the ATF6 pathway was shown to be pro-viral, the precise mechanism by which it facilitates PHEV replication remains unclear. The authors note the difficulty in detecting ATF6-Nt in their experiments, suggesting further investigation is needed.
- SG mechanism: The detailed mechanism by which stress granules suppress viral replication requires further elucidation.
- Viral countermeasures: The study suggests that viruses may evolve countermeasures to overcome p-eIF2α-mediated translation inhibition. Future work could explore whether PHEV possesses such mechanisms.
- Broader applicability: While this study focuses on PHEV, further research is needed to determine if these findings are generalizable to other coronaviruses, including SARS-CoV-2.
- In vivo complexity: While the study demonstrates UPR activation in vivo, the complex interplay of various cell types and immune responses in the brain warrants further investigation.
Summary updated